ReviewThe n-3 docosapentaenoic acid (DPA): A new player in the n-3 long chain polyunsaturated fatty acid family
-
Add time:08/27/2019 Source:sciencedirect.com
The n-3 docosapentaenoic acid (n-3 DPA) is less studied n-3 long-chain polyunsaturated fatty acid (LCPUFA), compared to its counterparts eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Present in food sources in non-negligible quantities, as well as in human milk, dietary n-3 DPA is of current interest both for its ability to increase EPA and DHA tissue status and for its specific or shared biological effects. Indeed, some evidence showed that dietary n-3 DPA is a source of EPA and slightly DHA in the major metabolic organs. n-3 DPA is also the precursor of a large panel of lipid mediators (protectins, resolvins, maresins, isoprostanes) principally implicated in the pro-resolution of the inflammation with specific effects compared to the other n-3 LCPUFA. Recent results showed that n-3 DPA is implied in the improvement of cardiovascular and metabolic disease risk markers, especially plasma lipid parameters, platelet aggregation, insulin sensitivity and cellular plasticity. Moreover, n-3 DPA is the most abundant n-3 LCPUFA in the brain after DHA and it could be specifically beneficial for elderly neuroprotection, and early-life development. These results led to the development of two drugs specifically containing n-3 DPA. This review summarizes the different knowledge about n-3 DPA direct and indirect sources, availability and purification methods, focusing thereafter on the recent findings showing n-3 DPA relationship with fatty acid metabolism, lipid mediators, Finally, the n-3 DPA biological and pharmacological effects are described.
We also recommend Trading Suppliers and Manufacturers of N(3)-2'-myristoyloxyethyl-N(6)-2'-hydroxyethyl-1,8-dioxotriethylenetetramine-N,N,N',N'-tetraacetic acid (cas 138420-02-7). Pls Click Website Link as below: cas 138420-02-7 suppliers
Prev:ResearchEffects of altering the ratio of dietary n-6 to n-3 fatty acids on spontaneous luteolysis in lactating dairy cows
Next:Dietary n-3 but not n-6 fatty acids down-regulate maternal dyslipidemia induced inflammation: A three-generation study in rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Effect of supplementing calcium salts of n-3 and n-6 fatty acid to pregnant nonlactating cows on colostrum composition, milk yield, and reproductive performance of dairy cows08/30/2019
- Effect of dietary soluble fibre and n-6/n-3 fatty acid ratio on growth performance and nitrogen and energy retention efficiency in growing rabbits08/29/2019
- Dietary n-3 but not n-6 fatty acids down-regulate maternal dyslipidemia induced inflammation: A three-generation study in rats08/28/2019
- ResearchEffects of altering the ratio of dietary n-6 to n-3 fatty acids on spontaneous luteolysis in lactating dairy cows08/26/2019
- Differential partitioning of rumen-protected n–3 and n–6 fatty acids into muscles with different metabolism08/25/2019
- Bioavailability of docosahexaenoic acid 22:6(n-3) from enantiopure triacylglycerols and their regioisomeric counterpart in rats08/24/2019
- Dynamic interactions of n-3 and n-6 fatty acid nutrients08/23/2019


